Cargando…

Hepatocellular adenomas: is there additional value in using Gd-EOB-enhanced MRI for subtype differentiation?

PURPOSE: To differentiate subtypes of hepatocellular adenoma (HCA) based on enhancement characteristics in gadoxetic acid (Gd-EOB) magnetic resonance imaging (MRI). MATERIALS AND METHODS: Forty-eight patients with 79 histopathologically proven HCAs who underwent Gd-EOB-enhanced MRI were enrolled (st...

Descripción completa

Detalles Bibliográficos
Autores principales: Auer, Timo Alexander, Fehrenbach, Uli, Grieser, Christian, Penzkofer, Tobias, Geisel, Dominik, Schmelzle, Moritz, Müller, Tobias, Bläker, Hendrik, Seehofer, Daniel, Denecke, Timm
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645538/
https://www.ncbi.nlm.nih.gov/pubmed/32086574
http://dx.doi.org/10.1007/s00330-020-06726-8
_version_ 1784610325925986304
author Auer, Timo Alexander
Fehrenbach, Uli
Grieser, Christian
Penzkofer, Tobias
Geisel, Dominik
Schmelzle, Moritz
Müller, Tobias
Bläker, Hendrik
Seehofer, Daniel
Denecke, Timm
author_facet Auer, Timo Alexander
Fehrenbach, Uli
Grieser, Christian
Penzkofer, Tobias
Geisel, Dominik
Schmelzle, Moritz
Müller, Tobias
Bläker, Hendrik
Seehofer, Daniel
Denecke, Timm
author_sort Auer, Timo Alexander
collection PubMed
description PURPOSE: To differentiate subtypes of hepatocellular adenoma (HCA) based on enhancement characteristics in gadoxetic acid (Gd-EOB) magnetic resonance imaging (MRI). MATERIALS AND METHODS: Forty-eight patients with 79 histopathologically proven HCAs who underwent Gd-EOB-enhanced MRI were enrolled (standard of reference: surgical resection). Two blinded radiologists performed quantitative measurements (lesion-to-liver enhancement) and evaluated qualitative imaging features. Inter-reader variability was tested. Advanced texture analysis was used to evaluate lesion heterogeneity three-dimensionally. RESULTS: Overall, there were 19 (24%) hepatocyte nuclear factor (HNF)-1a-mutated (HHCAs), 37 (47%) inflammatory (IHCAs), 5 (6.5%) b-catenin-activated (bHCA), and 18 (22.5%) unclassified (UHCAs) adenomas. In the hepatobiliary phase (HBP), 49.5% (39/79) of all adenomas were rated as hypointense and 50.5% (40/79) as significantly enhancing (defined as > 25% intralesional GD-EOB uptake). 82.5% (33/40) of significantly enhancing adenomas were IHCAs, while only 4% (1/40) were in the HHCA subgroup (p < 0.001). When Gd-EOB uptake behavior was considered in conjunction with established MRI features (binary regression model), the area under the curve (AUC) increased from 0.785 to 0.953 for differentiation of IHCA (atoll sign + hyperintensity), from 0.859 to 0.903 for bHCA (scar + hyperintensity), and from 0.899 to 0.957 for HHCA (steatosis + hypointensity). Three-dimensional region of interest (3D ROI) analysis showed significantly increased voxel heterogeneity for IHCAs (p = 0.038). CONCLUSION: Gd-EOB MRI is of added value for subtype differentiation of HCAs and reliably identifies the typical heterogeneous HBP uptake of IHCAs. Diagnostic accuracy can be improved significantly by the combined analysis of established morphologic MR appearances and intralesional Gd-EOB uptake. KEY POINTS: • Gd-EOB-enhanced MRI is of added value for subtype differentiation of HCA. • IHCA and HHCA can be identified reliably based on their typical Gd-EOB uptake patterns, and accuracy increases significantly when additionally taking established MR appearances into account. • The small numbers of bHCAs and UHCAs remain the source of diagnostic uncertainty.
format Online
Article
Text
id pubmed-8645538
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-86455382021-12-08 Hepatocellular adenomas: is there additional value in using Gd-EOB-enhanced MRI for subtype differentiation? Auer, Timo Alexander Fehrenbach, Uli Grieser, Christian Penzkofer, Tobias Geisel, Dominik Schmelzle, Moritz Müller, Tobias Bläker, Hendrik Seehofer, Daniel Denecke, Timm Eur Radiol Hepatobiliary-Pancreas PURPOSE: To differentiate subtypes of hepatocellular adenoma (HCA) based on enhancement characteristics in gadoxetic acid (Gd-EOB) magnetic resonance imaging (MRI). MATERIALS AND METHODS: Forty-eight patients with 79 histopathologically proven HCAs who underwent Gd-EOB-enhanced MRI were enrolled (standard of reference: surgical resection). Two blinded radiologists performed quantitative measurements (lesion-to-liver enhancement) and evaluated qualitative imaging features. Inter-reader variability was tested. Advanced texture analysis was used to evaluate lesion heterogeneity three-dimensionally. RESULTS: Overall, there were 19 (24%) hepatocyte nuclear factor (HNF)-1a-mutated (HHCAs), 37 (47%) inflammatory (IHCAs), 5 (6.5%) b-catenin-activated (bHCA), and 18 (22.5%) unclassified (UHCAs) adenomas. In the hepatobiliary phase (HBP), 49.5% (39/79) of all adenomas were rated as hypointense and 50.5% (40/79) as significantly enhancing (defined as > 25% intralesional GD-EOB uptake). 82.5% (33/40) of significantly enhancing adenomas were IHCAs, while only 4% (1/40) were in the HHCA subgroup (p < 0.001). When Gd-EOB uptake behavior was considered in conjunction with established MRI features (binary regression model), the area under the curve (AUC) increased from 0.785 to 0.953 for differentiation of IHCA (atoll sign + hyperintensity), from 0.859 to 0.903 for bHCA (scar + hyperintensity), and from 0.899 to 0.957 for HHCA (steatosis + hypointensity). Three-dimensional region of interest (3D ROI) analysis showed significantly increased voxel heterogeneity for IHCAs (p = 0.038). CONCLUSION: Gd-EOB MRI is of added value for subtype differentiation of HCAs and reliably identifies the typical heterogeneous HBP uptake of IHCAs. Diagnostic accuracy can be improved significantly by the combined analysis of established morphologic MR appearances and intralesional Gd-EOB uptake. KEY POINTS: • Gd-EOB-enhanced MRI is of added value for subtype differentiation of HCA. • IHCA and HHCA can be identified reliably based on their typical Gd-EOB uptake patterns, and accuracy increases significantly when additionally taking established MR appearances into account. • The small numbers of bHCAs and UHCAs remain the source of diagnostic uncertainty. Springer Berlin Heidelberg 2020-02-21 2020 /pmc/articles/PMC8645538/ /pubmed/32086574 http://dx.doi.org/10.1007/s00330-020-06726-8 Text en © The Author(s) 2020, corrected publication 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Hepatobiliary-Pancreas
Auer, Timo Alexander
Fehrenbach, Uli
Grieser, Christian
Penzkofer, Tobias
Geisel, Dominik
Schmelzle, Moritz
Müller, Tobias
Bläker, Hendrik
Seehofer, Daniel
Denecke, Timm
Hepatocellular adenomas: is there additional value in using Gd-EOB-enhanced MRI for subtype differentiation?
title Hepatocellular adenomas: is there additional value in using Gd-EOB-enhanced MRI for subtype differentiation?
title_full Hepatocellular adenomas: is there additional value in using Gd-EOB-enhanced MRI for subtype differentiation?
title_fullStr Hepatocellular adenomas: is there additional value in using Gd-EOB-enhanced MRI for subtype differentiation?
title_full_unstemmed Hepatocellular adenomas: is there additional value in using Gd-EOB-enhanced MRI for subtype differentiation?
title_short Hepatocellular adenomas: is there additional value in using Gd-EOB-enhanced MRI for subtype differentiation?
title_sort hepatocellular adenomas: is there additional value in using gd-eob-enhanced mri for subtype differentiation?
topic Hepatobiliary-Pancreas
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645538/
https://www.ncbi.nlm.nih.gov/pubmed/32086574
http://dx.doi.org/10.1007/s00330-020-06726-8
work_keys_str_mv AT auertimoalexander hepatocellularadenomasisthereadditionalvalueinusinggdeobenhancedmriforsubtypedifferentiation
AT fehrenbachuli hepatocellularadenomasisthereadditionalvalueinusinggdeobenhancedmriforsubtypedifferentiation
AT grieserchristian hepatocellularadenomasisthereadditionalvalueinusinggdeobenhancedmriforsubtypedifferentiation
AT penzkofertobias hepatocellularadenomasisthereadditionalvalueinusinggdeobenhancedmriforsubtypedifferentiation
AT geiseldominik hepatocellularadenomasisthereadditionalvalueinusinggdeobenhancedmriforsubtypedifferentiation
AT schmelzlemoritz hepatocellularadenomasisthereadditionalvalueinusinggdeobenhancedmriforsubtypedifferentiation
AT mullertobias hepatocellularadenomasisthereadditionalvalueinusinggdeobenhancedmriforsubtypedifferentiation
AT blakerhendrik hepatocellularadenomasisthereadditionalvalueinusinggdeobenhancedmriforsubtypedifferentiation
AT seehoferdaniel hepatocellularadenomasisthereadditionalvalueinusinggdeobenhancedmriforsubtypedifferentiation
AT denecketimm hepatocellularadenomasisthereadditionalvalueinusinggdeobenhancedmriforsubtypedifferentiation